Overview
Ioannis Kalomenidis practices in Athens, Greece. Mr. Kalomenidis is rated as an Advanced expert by MediFind in the treatment of Pleurisy. His top areas of expertise are Pleural Effusion, COVID-19, Pleurisy, and Mesothelioma.
His clinical research consists of co-authoring 73 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 6 articles in the study of Pleurisy.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Elite
- Pleural EffusionMr. Kalomenidis isElite. Learn about Pleural Effusion.
- Distinguished
- COVID-19Mr. Kalomenidis isDistinguished. Learn about COVID-19.
- Advanced
- Lactic AcidosisMr. Kalomenidis isAdvanced. Learn about Lactic Acidosis.
- MesotheliomaMr. Kalomenidis isAdvanced. Learn about Mesothelioma.
- PleurisyMr. Kalomenidis isAdvanced. Learn about Pleurisy.
- Experienced
- Acute Respiratory Distress Syndrome (ARDS)Mr. Kalomenidis isExperienced. Learn about Acute Respiratory Distress Syndrome (ARDS).
- AsthmaMr. Kalomenidis isExperienced. Learn about Asthma.
- EmpyemaMr. Kalomenidis isExperienced. Learn about Empyema.
- Hospital-Acquired PneumoniaMr. Kalomenidis isExperienced. Learn about Hospital-Acquired Pneumonia.
- Long Haul COVIDMr. Kalomenidis isExperienced. Learn about Long Haul COVID.
- Lung AdenocarcinomaMr. Kalomenidis isExperienced. Learn about Lung Adenocarcinoma.